These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32793156)

  • 1. The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design.
    León-Buitimea A; Garza-Cárdenas CR; Garza-Cervantes JA; Lerma-Escalera JA; Morones-Ramírez JR
    Front Microbiol; 2020; 11():1669. PubMed ID: 32793156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance.
    León-Buitimea A; Garza-Cárdenas CR; Román-García MF; Ramírez-Díaz CA; Ulloa-Ramírez M; Morones-Ramírez JR
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Antimicrobial Drug in the Development of Potential Therapeutics.
    Mayegowda SB; Ng M; Alghamdi S; Atwah B; Alhindi Z; Islam F
    Evid Based Complement Alternat Med; 2022; 2022():2500613. PubMed ID: 35571735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Synthesis of Novel Antimicrobial Agents.
    Breijyeh Z; Karaman R
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial Efficacy of Polysaccharide Capped Silver Nanoparticles Is Not Compromised by AcrAB-TolC Efflux Pump.
    Mishra M; Kumar S; Majhi RK; Goswami L; Goswami C; Mohapatra H
    Front Microbiol; 2018; 9():823. PubMed ID: 29780364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials.
    Sousa SA; Feliciano JR; Pita T; Soeiro CF; Mendes BL; Alves LG; Leitão JH
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
    Spera AM; Esposito S; Pagliano P
    Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-only, antimicrobial peptide-containing recombinant nanoparticles with inherent built-in antibacterial activity.
    Serna N; Sánchez-García L; Sánchez-Chardi A; Unzueta U; Roldán M; Mangues R; Vázquez E; Villaverde A
    Acta Biomater; 2017 Sep; 60():256-263. PubMed ID: 28735028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
    Yuan YG; Peng QL; Gurunathan S
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.